Filter
288
Filtered Results: 288
Text search:
FDC
Featured
Recommendations
45
New Publications
106
Language
Document type
No document type
218
Guidelines
24
Studies & Reports
21
Training Material
9
Manuals
6
Fact sheets
5
Strategic & Response Plan
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
25
Tanzania
13
Kenya
11
South Africa
11
Namibia
9
Malawi
8
Zambia
6
Indonesia
6
Nepal
5
Ghana
5
Burkina Faso
5
Bangladesh
5
Uganda
5
Nigeria
4
Zimbabwe
4
Mozambique
4
Cambodia
4
Ethiopia
4
Philippines
3
Liberia
3
Sierra Leone
2
Global
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Botswana
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Tajikistan
1
Timor Leste/ East Timor
1
Ukraine
1
Lesotho
1
Gambia
1
Rwanda
1
Cameroon
1
Albania
1
Senegal
1
Afghanistan
1
Haiti
1
Western and Central Europe
1
Paraguay
1
Gabon
1
Sri Lanka
1
Libya
1
Bhutan
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
148
Clinical Guidelines
41
Capacity Building
8
Public Health
7
Pharmacy & Technologies
7
Women & Child Health
3
Key Resources
3
Toolboxes
TB
68
HIV
47
AMR
18
Pharmacy
13
NTDs
4
Polio
4
Caregiver
3
NCDs
3
Refugee
2
COVID-19
2
Specific Hazards
1
Global Health Education
1
Accessed November 2017
Accessed November 2017
A manual for programme managers.
БОРЬБА С ТУБЕРКУЛЕЗОМ В ТЮРЬМАХ
Руководство для руководителей программ
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
The END TB Strategy
Vol. 2: Clinicians' Guide
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Clinicians’ Guide is designed to assist busy medical practitioners in the field with patient management by providing current, essential, practical guidance and background, packaged into a single resource
Reducing the humanitarian impact of the use of explosive weapons in populated areas is a key priority for the United
Nations, the International Committee of the Red Cross (ICRC), civil society and an increasing number of Member States.
The United Nations Secretary-General has expressly called on...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Vinay P. Saldanha( UNAIDS Regional Director- Eastern Europe & Central Asia)
Session 1 Wednesday 30/01/2019
30-31 January 2019, Bucharest
Accessed: 29.09.2019
Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019
Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office
of AIDS Research Advisory Council (OARAC)
MSF International AIDS Working Group
It's time to deliver differently.
Accessed: 13.11.2019
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
